PG delivers modest sales growth in Q2 but faces margin pressure, tariff headwinds and soft EPS outlook, as premium valuation ...
In slides for its investor day presentation, Procter & Gamble shared a long-term growth algorithm that includes organic sales to grow ahead of the market; core EPS to grow mid-to-high single digits; ...
Procter & Gamble: Weak Fundamentals Could Result In A Painful Shave For Investors (Rating Downgrade)
Procter & Gamble downgraded to strong sell after weak results, stalled organic growth, and market share losses. Click here to read why PG is a Strong Sell.
Procter & Gamble has consistently underperformed the S&P 500, with the company's recent performance worsening. The company's reliance on price increases is unsustainable, as shown by limited pricing ...
Macquarie Asset Management, an investment management company, released its “Macquarie Core Equity Fund” investor letter for the second quarter of 2025. A copy of the letter can be downloaded here. The ...
In a strategic move to revitalize its health portfolio, Procter & Gamble announced the acquisition of Wonderbelly on January ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results